Aurobindo Pharma Share price

Aurobindo Pharma Limited is one of the leadingmanufacturers of life saving anti-biotic bulk drugs inIndia with excellent track record of profitability andgrowth.The company was incorporated on 26-12-1986 as a PrivateLimited company and was converted into a Public Limitedcompany with effect from 30-4-1992. The company Isregistered with the Registrar of Companies. Andhra Pradeshat Hyderabad.The first unit of the Company is located at Pondicherry. TheSemi Synthetic Penicillin bulk drugs namely Ampicillin andAmoxycillin are manufactured in this Unit. In addition theCompany also manufactures 6 APA an intermediate requiredfor anti-biotic in the same plant.The company commenced commercial production of antibioticsin the year 1988. The installed capacity of this unit isincreased from 204 TPA to 300 TPA during the current year1994-95.The Company has set up two more units during the year 1993- ''94.They are :i) Bulk drug unit at Bollaram near Hyderabad.ii) Formulations unit at Kukatpally near Hyderabad.The Bollaram unit is for the manufacture of anti-bioticbulk drugs namely Cloxacillin and Dicloxacillin mainlyfor exports. The commercial production in this unitcommenced from April 1994. These manufacturing facilitiesare versatile.During the Current Year 1994-95 the Company has upgradedthe plant and increased the installed capacity from 78 TPAto 84 TPA. The Company has set up a separate block in thesame premises during the current year 1994-95 formanufacture of high value drugs namely AstemizoleDomeperidone Famotidine and Omeprazole with an installedcapacity of 9 TPA.The Kukatpally unit is for manufacture of pharmaceuticalformulations with an installed capacity of 360 lakhstablets and 480 lakhs capsules per annum. The commercialproduction for capsules in this unit has commenced fromApril 1994.Another unit was also set up for the manufacture of CMICChloride a bulk drug intermediate at Pashamylaram nearHyderabad in the Year 1992 through another Companynamely Chaitanya Organics Pvt. Ltd. which is now beingmerged with Aurobindo Pharma Limited. During the currentyear 1994-95 the Company has increased the installedcapacity of this unit from 120 TPA to 144 TPA. Further anew bulk drug intermediate namely DCMIC Chloride is alsomanufactured in this unit from April 1994. The Companyhas also expanded the above unit by setting up a separateblock for manufacture of Norfloxacillin and Pefloxacillinwith an installed capacity of 60 TPA.